Related Articles
Antitumor activity of nimotuzumab in combination with cisplatin in lung cancer cell line A549 in vitro
Nimotuzumab, an EGFR‑targeted antibody, promotes radiosensitivity of recurrent esophageal squamous cell carcinoma
Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab
Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer
Effect of ECRG2 in combination with cisplatin on the proliferation and apoptosis of EC9706 cells